Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update [Yahoo! Finance]
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update
Agenus (AGEN) Presents New Phase 1b Clinical Data on BOT/BAL Combination for MSS mCRC [Yahoo! Finance]
Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL
??????????????????????:?????????2035????1,754?8,000??????????? [CNET News]